BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

809 related articles for article (PubMed ID: 18006828)

  • 1. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.
    Yamashita T; Budhu A; Forgues M; Wang XW
    Cancer Res; 2007 Nov; 67(22):10831-9. PubMed ID: 18006828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.
    Yamashita T; Forgues M; Wang W; Kim JW; Ye Q; Jia H; Budhu A; Zanetti KA; Chen Y; Qin LX; Tang ZY; Wang XW
    Cancer Res; 2008 Mar; 68(5):1451-61. PubMed ID: 18316609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma.
    Terris B; Cavard C; Perret C
    J Hepatol; 2010 Feb; 52(2):280-1. PubMed ID: 20006402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features.
    Yamashita T; Ji J; Budhu A; Forgues M; Yang W; Wang HY; Jia H; Ye Q; Qin LX; Wauthier E; Reid LM; Minato H; Honda M; Kaneko S; Tang ZY; Wang XW
    Gastroenterology; 2009 Mar; 136(3):1012-24. PubMed ID: 19150350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of wnt/β-catenin Signaling in Hepatocellular Carcinoma by an Antipsychotic Drug Pimozide.
    Fako V; Yu Z; Henrich CJ; Ransom T; Budhu AS; Wang XW
    Int J Biol Sci; 2016; 12(7):768-75. PubMed ID: 27313491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the relationship among microRNA-181, epithelial cell-adhesion molecule (EpCAM) and beta-catenin in hepatic cancer stem cells.
    Li JP; Zheng JY; Du JJ; Zhang R; Yang AG
    Hepatology; 2009 Dec; 50(6):2047-8; author reply 448. PubMed ID: 19937678
    [No Abstract]   [Full Text] [Related]  

  • 7. De novo HAPLN1 expression hallmarks Wnt-induced stem cell and fibrogenic networks leading to aggressive human hepatocellular carcinomas.
    Mebarki S; Désert R; Sulpice L; Sicard M; Desille M; Canal F; Dubois-Pot Schneider H; Bergeat D; Turlin B; Bellaud P; Lavergne E; Le Guével R; Corlu A; Perret C; Coulouarn C; Clément B; Musso O
    Oncotarget; 2016 Jun; 7(26):39026-39043. PubMed ID: 27191501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis.
    Cheng AS; Lau SS; Chen Y; Kondo Y; Li MS; Feng H; Ching AK; Cheung KF; Wong HK; Tong JH; Jin H; Choy KW; Yu J; To KF; Wong N; Huang TH; Sung JJ
    Cancer Res; 2011 Jun; 71(11):4028-39. PubMed ID: 21512140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the Wnt/B-catenin/TCF4 pathway using SAGE, genome-wide microarray and promoter analysis: Identification of BRI3 and HSF2 as novel targets.
    Kavak E; Najafov A; Ozturk N; Seker T; Cavusoglu K; Aslan T; Duru AD; Saygili T; Hoxhaj G; Hiz MC; Unal DO; Birgül-Iyison N; Ozturk M; Koman A
    Cell Signal; 2010 Oct; 22(10):1523-35. PubMed ID: 20538055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells.
    Yang W; Yan HX; Chen L; Liu Q; He YQ; Yu LX; Zhang SH; Huang DD; Tang L; Kong XN; Chen C; Liu SQ; Wu MC; Wang HY
    Cancer Res; 2008 Jun; 68(11):4287-95. PubMed ID: 18519688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma.
    Jia Y; Yang Y; Liu S; Herman JG; Lu F; Guo M
    Epigenetics; 2010; 5(8):743-9. PubMed ID: 20716954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-Fluorouracil by inducing hepatocytic differentiation.
    Yamashita T; Honda M; Nio K; Nakamoto Y; Yamashita T; Takamura H; Tani T; Zen Y; Kaneko S
    Cancer Res; 2010 Jun; 70(11):4687-97. PubMed ID: 20484035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma.
    Fatima S; Lee NP; Tsang FH; Kolligs FT; Ng IO; Poon RT; Fan ST; Luk JM
    Oncogene; 2012 Sep; 31(38):4233-44. PubMed ID: 22249261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prickle-1 negatively regulates Wnt/beta-catenin pathway by promoting Dishevelled ubiquitination/degradation in liver cancer.
    Chan DW; Chan CY; Yam JW; Ching YP; Ng IO
    Gastroenterology; 2006 Oct; 131(4):1218-27. PubMed ID: 17030191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel candidate targets of Wnt/beta-catenin signaling in hepatoma cells.
    Lee HS; Park MH; Yang SJ; Park KC; Kim NS; Kim YS; Kim DI; Yoo HS; Choi EJ; Yeom YI
    Life Sci; 2007 Jan; 80(7):690-8. PubMed ID: 17157329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. βII-Spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and Wnt signaling by regulation of Wnt inhibitor kallistatin.
    Zhi X; Lin L; Yang S; Bhuvaneshwar K; Wang H; Gusev Y; Lee MH; Kallakury B; Shivapurkar N; Cahn K; Tian X; Marshall JL; Byers SW; He AR
    Hepatology; 2015 Feb; 61(2):598-612. PubMed ID: 25307947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of EpCAM overexpression on human breast cancer cell lines.
    Gostner JM; Fong D; Wrulich OA; Lehne F; Zitt M; Hermann M; Krobitsch S; Martowicz A; Gastl G; Spizzo G
    BMC Cancer; 2011 Jan; 11():45. PubMed ID: 21281469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput screening for identification of inhibitors of EpCAM-dependent growth of hepatocellular carcinoma cells.
    Henrich CJ; Budhu A; Yu Z; Evans JR; Goncharova EI; Ransom TT; Wang XW; McMahon JB
    Chem Biol Drug Des; 2013 Aug; 82(2):131-9. PubMed ID: 23879724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
    Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc finger transcription factor 191, directly binding to β-catenin promoter, promotes cell proliferation of hepatocellular carcinoma.
    Liu G; Jiang S; Wang C; Jiang W; Liu Z; Liu C; Saiyin H; Yang X; Shen S; Jiang D; Zhou P; Han D; Hu X; Yi Q; Yu L
    Hepatology; 2012 Jun; 55(6):1830-9. PubMed ID: 22213192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.